Akebia Therapeutics to Present at the Jefferies Global Healthcare Conference
Breakeven On The Horizon For Akebia Therapeutics, Inc. (NASDAQ:AKBA)
With the business potentially at an important milestone, we thought we'd take a closer look at Akebia Therapeutics, Inc.'s (NASDAQ:AKBA) future prospects. Akebia Therapeutics, Inc., a biopharmaceutic
Revenue Downgrade: Here's What Analysts Forecast For Akebia Therapeutics, Inc. (NASDAQ:AKBA)
Akebia Therapeutics Reports Q1 2024 Financial Results: A Detailed Overview
Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q1 2024 Earnings Call Transcript
Akebia Therapeutics First Quarter 2024 Earnings: Misses Expectations
Akebia Therapeutics(AKBA.US) Officer Sells US$31,050 in Common Stock
$Akebia Therapeutics(AKBA.US)$ Officer Burke Steven Keith sold 27,000 shares of common stock on Aug 25, 2023 at an average price of $1.15 for a total value of $31,050.Source: Announcement What is stat
Tivic Health, RAPT Therapeutics, Notable Labs Among Healthcare Movers
Express News | Akebia Therapeutics Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 Financial Results
Earnings Flash (AKBA) AKEBIA THERAPEUTICS Reports Q1 Revenue $32.6M
07:14 AM EDT, 05/09/2024 (MT Newswires) -- Earnings Flash (AKBA) AKEBIA THERAPEUTICS Reports Q1 Revenue $32.6M
Akebia Therapeutics | 10-Q: Quarterly report
Express News | Akebia Therapeutics: Existing Cash Resources Sufficient to Fund Current Operating Plan, Including U.S. Vafseo Launch, for at Least Next 2 Years
Express News | Akebia Therapeutics Q1 Operating Income USD -14.936 Million
Express News | Akebia Therapeutics Q1 Basic EPS USD -0.09
Express News | Akebia Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
Express News | Akebia Therapeutics Q1 Net Income USD -17.985 Million
Express News | Akebia Therapeutics Q1 Operating Expenses USD 35.938 Million
Akebia Therapeutics 1Q Loss/Shr 9c >AKBA
Akebia Therapeutics 1Q Loss/Shr 9c >AKBA
Akebia Therapeutics to Report First Quarter 2024 Financial Results and Discuss Recent Business Highlights
Akebia Therapeutics, Inc. (Nasdaq: AKBA) today announced plans to release its financial results for the first quarter ended March 31, 2024, on...
When Can We Expect A Profit From Akebia Therapeutics, Inc. (NASDAQ:AKBA)?